Image
|
Figure Caption
Fig. 1 Figure 1 Schematic representing the study design for use of Divya-Swasari-Vati (DSV) as a therapeutic against SARS-CoV-2 in a humanized zebrafish model. Treatment end points were studied for 4 and 7 days. A parallel experiment was also setup to study the survival of the different groups for 10 days. Transplanted A549 cells in the swim bladder are highlighted by yellow circles and shown as a magnified image.
Acknowledgments
This image is the copyrighted work of the attributed author or publisher, and
ZFIN has permission only to display this image to its users.
Additional permissions should be obtained from the applicable author or publisher of the image.
Full text @ J Inflamm Res